Phage therapy shown to kill drug-resistant superbug

Scientists from the University of Liverpool‘s Institute of Infection and Global Health have shown that phage therapy could offer a safe and effective alternative to antibitotics in the treatment of cystic fibrosis lung infections.

Chronic lung infections caused by the bacterium Pseudomonas aeruginosa are becoming increasingly difficult to treat due to (AMR). With limited alternative therapeutic options available this has led to a renewed interest in (bacterio).